Related Experiment Video

Updated: May 12, 2026

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry (CE-ICP-MS) for Quantification of Iron Redox Species (Fe(II), Fe(III))
04:48

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry (CE-ICP-MS) for Quantification of Iron Redox Species (Fe(II), Fe(III))

Published on: May 4, 2020

Iron's role in paediatric restless legs syndrome - a review

Cara Dosman1, Manisha Witmans, Lonnie Zwaigenbaum

  • 1Department of Pediatrics, University of Alberta, Edmonton, Alberta.

Paediatrics & Child Health
|April 2, 2013
PubMed

Insights

Pediatric restless legs syndrome (RLS) treatment is crucial for child development. Oral iron may help RLS in children with low ferritin, but more research is needed.

Area of Science:

  • Pediatric Neurology
  • Sleep Medicine
  • Developmental Pediatrics

Background:

  • Restless Legs Syndrome (RLS) in children causes sleep disturbances, impacting development and family well-being.
  • RLS is linked to iron deficiency and dopaminergic system issues.
  • Diagnostic criteria for pediatric RLS are evolving and challenging, particularly in preschoolers.

Purpose of the Study:

  • To highlight the importance of RLS treatment in children.
  • To discuss diagnostic challenges and current management strategies for pediatric RLS.
  • To inform community physicians about RLS recognition and referral.

Main Methods:

  • Review of current understanding of pediatric RLS pathophysiology.
  • Analysis of diagnostic criteria and their limitations.
  • Evaluation of treatment recommendations, including iron supplementation and behavioral strategies.

Main Results:

  • Pediatric RLS treatment is vital due to associated developmental and behavioral issues.
  • Oral iron therapy (3-6 mg/kg/day for 3 months) is suggested for ferritin <50 ug/L, despite limited evidence.
  • Sleep hygiene and behavioral interventions are recommended adjuncts.

Conclusions:

  • Early recognition and referral of pediatric RLS by community physicians are essential.
  • While iron therapy shows promise, its efficacy requires further research.
  • Safe iron supplementation necessitates monitoring of iron metabolism parameters.

Keywords:
Child psychologyIronIron-deficiency anemiaRestless legs syndromeTherapeutics

More Related Videos

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

Related Concept Videos

Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...